Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/1998
08/18/1998US5795965 Reshaped human to human interleukin-6 receptor
08/18/1998US5795963 Amyloid precursor protein in alzheimer's disease
08/18/1998US5795955 Amino acid sequences, t-cell epitopes of gag protein for htlv and amino acid sequences for b-cell epitopes and hybrid loops
08/18/1998US5795862 Ectoparasite saliva proteins and apparatus to collect such proteins
08/18/1998US5795859 Peptide which abrogates TNF and/or LPS toxicity
08/18/1998US5795778 Using enzymatic rna compound
08/18/1998US5795768 Genetic engineering
08/18/1998US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
08/18/1998US5795757 DNA encoding threonyl tRNA synthetase from staphylococcus aureus
08/18/1998US5795743 A (glyco)protein
08/18/1998US5795741 Nucleic acid molecules with codes for proteins with amino acid sequences for vaccines
08/18/1998US5795735 Isolated polynucleotides encoding PKA-binding proteins and methods of producing the proteins recombinantly
08/18/1998US5795582 Adjuvant properties of poly (amidoamine) dendrimers
08/18/1998US5795580 Group B streptococcus type V polysaccharide-protein conjugate vaccines
08/18/1998US5795579 Herpes simplex virus VP16 vaccines
08/18/1998US5795578 Vaccine against equine herpesvirus type 1
08/18/1998US5795577 Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S.
08/18/1998US5795572 Monoclonal antibodies and FV specific for CD2 antigen
08/13/1998WO1998035045A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
08/13/1998WO1998035034A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
08/13/1998WO1998035029A1 Synthetic genes for recombinant mycobacterium proteins
08/13/1998WO1998035023A1 Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays
08/13/1998WO1998035019A1 Growth differentiation factor-11
08/13/1998WO1998034968A1 Polymers incorporating peptides
08/13/1998WO1998034957A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE α-GALACTOSYL EPITOPE
08/13/1998WO1998034956A1 Non-covalent complex comprising at least an antibody and element binding with immunoglobulins associated with an active substance, method of preparing and applications
08/13/1998WO1998034954A2 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
08/13/1998WO1998034643A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms
08/13/1998WO1998034642A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998WO1998034641A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
08/13/1998WO1998034640A2 Synthetic hiv gag genes
08/13/1998WO1998034639A1 Immunization against endogenous molecules
08/13/1998WO1998034635A1 Methods and compositions for the inhibition of interleukin-12 production
08/13/1998WO1998034632A1 Compounds and compositions for delivering active agents
08/13/1998WO1998034594A1 Thimerosal-free preservatives for vaccines
08/13/1998WO1998030709A3 Non-immunogenic prodrugs and selectable markers for use in gene therapy
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998026798A3 IMMUNIZATION AGAINST NEISSERIA GONORRHOEAE AND $i(NEISSERIA MENINGITIDIS)
08/13/1998WO1998024888A3 Polypeptides encoded by a human lipase-like gene, compositions and methods
08/13/1998WO1998018917A3 RIBOFLAVIN MUTANTS AS VACCINES AGAINST $i(ACTINOBACILLUS PLEUROPNEUMONIAE)
08/13/1998WO1998013501A3 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
08/13/1998WO1998007851A3 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans
08/13/1998DE19735118C1 Papilloma virus DNA
08/13/1998CA2281792A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
08/13/1998CA2281699A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
08/13/1998CA2280945A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998CA2280195A1 Synthetic hiv gag genes
08/13/1998CA2279868A1 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
08/13/1998CA2279834A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms
08/13/1998CA2279826A1 Immunization against endogenous molecules
08/12/1998EP0857787A2 Histidine kinase from Staphylococcus aureaus
08/12/1998EP0857786A1 RNA dependent amidotransferase B from Staphylococcus Aureus
08/12/1998EP0857785A1 RNA dependent amidotransferase C from Staphylococcus Aureus
08/12/1998EP0857782A2 Novel mammalian DD-1 gene
08/12/1998EP0857781A2 Human endoglingene promoter and use thereof
08/12/1998EP0857486A2 Mixture of external membranes and/or cell wall from bacteria for oral immunisation against mucosal infections
08/12/1998EP0857485A2 Use of acemannan for the treatment of multiple sclerosis and for the correction of malabsorption
08/12/1998EP0857214A1 Novel saliva binding protein
08/12/1998EP0857210A1 Therapeutic antiangiogenic compositions and methods
08/12/1998EP0857209A1 Fibroblast growth factor 13
08/12/1998EP0857176A1 HUMAN EPITHELIAL ANTIGEN Ep-CAM DERIVED PEPTIDES AND THEIR USE
08/12/1998EP0857175A1 Novel human cysteine protease
08/12/1998EP0857069A1 Methods of preserving microorganisms
08/12/1998EP0857068A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes
08/12/1998EP0857061A1 Solubilisation methods
08/12/1998EP0857059A1 Novel adjuvant compositions and vaccine formulations comprising same
08/12/1998EP0639071B1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil
08/12/1998EP0636177B1 Isolation, characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin e
08/12/1998CN1190438A Chimeric proteins for use in transport of selected substance into cells
08/12/1998CN1190349A Viral agent associated with mystery swine disease
08/12/1998CN1190127A Attenuated live neospora vaccine
08/12/1998CA2223029A1 Canine parvovirus dna vaccines
08/11/1998US5792849 Polypeptides useful for the stimulation of glial cell (particularly, schwann cell) mitogenesis and treating glial cell tumors
08/11/1998US5792838 Method for stabilizing immunoglobulin compositions
08/11/1998US5792834 Polyethylene-protein conjugates
08/11/1998US5792832 Peptides from mammalian pancreatic cholesterol esterase
08/11/1998US5792648 Isolated, purified polynucleotide sequence encoding polypeptide having specified amino acid sequence
08/11/1998US5792644 DNA encoding an Eimeria 200 kd antigen
08/11/1998US5792624 Dirofilaria and onchocerca larval L3 cysteine protease proteins and uses thereof
08/11/1998US5792506 Disulfide bonds are reduced to sulfhydryl decreasing allergenicity of feeds
08/11/1998US5792463 Hybrid particle immunogens
08/11/1998US5792459 HIV-1 envelope muteins lacking hypervariable domains
08/11/1998US5792457 Antibody recognizing endothelial cell ligand for leukocyte CR3
08/11/1998US5792456 Mutant BR96 antibodies reactive with human carcinomas
08/11/1998US5792455 Anti-idiotypic antibody vaccines
08/11/1998US5792452 Live salmonella vaccine having an increased stability
08/11/1998CA2217321A1 Polymers incorporating peptides
08/11/1998CA1339990C Compositions and method for the treatment or prophylaxis of sepsis or septic shock
08/10/1998CA2223008A1 Def1
08/07/1998CA2222987A1 Novel compounds
08/07/1998CA2222984A1 Novel rat
08/07/1998CA2222978A1 Novel compounds
08/07/1998CA2222961A1 Novel compounds
08/07/1998CA2222957A1 Novel histidine kinase
08/06/1998WO1998034117A1 Cathepsin k and breast cancer
08/06/1998WO1998033928A1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector
08/06/1998WO1998033925A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998WO1998033923A1 MUTANT msbB or htrB GENES
08/06/1998WO1998033919A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998WO1998033908A1 Human c5a-like receptor
1 ... 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 ... 1823